Annual SG&A:
$61.08M-$33.92M(-35.70%)Summary
- As of today, VRDN annual SG&A is $61.08 million, with the most recent change of -$33.92 million (-35.70%) on December 31, 2024.
- During the last 3 years, VRDN annual SG&A has risen by +$35.28 million (+136.71%).
- VRDN annual SG&A is now -35.70% below its all-time high of $95.00 million, reached on December 31, 2023.
Performance
VRDN SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$17.10M(-100.00%)Summary
- As of today, VRDN quarterly SG&A is $0.00, with the most recent change of -$17.10 million (-100.00%) on June 30, 2025.
- Over the past year, VRDN quarterly SG&A has dropped by -$16.07 million (-100.00%).
- VRDN quarterly SG&A is now -100.00% below its all-time high of $32.99 million, reached on December 31, 2023.
Performance
VRDN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$4.18B-$344.06M(-8.97%)Summary
- As of today, VRDN TTM SG&A is -$4.18 billion, with the most recent change of -$344.06 million (-8.97%) on June 30, 2025.
- Over the past year, VRDN TTM SG&A has dropped by -$4.26 billion (-5015.89%).
- VRDN TTM SG&A is now -17391.78% below its all-time high of -$23.89 million.
Performance
VRDN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
VRDN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -35.7% | -100.0% | -5015.9% |
| 3Y3 Years | +136.7% | -100.0% | -10000.0% |
| 5Y5 Years | +424.5% | -100.0% | -10000.0% |
VRDN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -35.7% | +136.7% | -100.0% | at low | -225.0% | at low |
| 5Y | 5-Year | -35.7% | +424.5% | -100.0% | at low | -484.2% | at low |
| All-Time | All-Time | -35.7% | +3370.6% | -100.0% | at low | >-9999.0% | at low |
VRDN Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $31.51M(-33.8%) |
| Mar 2025 | - | $17.10M(>+9900.0%) | $47.58M(+4.6%) |
| Dec 2024 | $61.08M(-35.7%) | $0.00(-100.0%) | $45.50M(-42.0%) |
| Sep 2024 | - | $14.41M(-10.3%) | $78.49M(-7.7%) |
| Jun 2024 | - | $16.07M(+6.9%) | $85.00M(-3.6%) |
| Mar 2024 | - | $15.03M(-54.5%) | $88.19M(-7.2%) |
| Dec 2023 | $95.00M(+170.0%) | $32.99M(+57.8%) | $95.00M(+32.2%) |
| Sep 2023 | - | $20.91M(+8.5%) | $71.86M(+20.1%) |
| Jun 2023 | - | $19.26M(-11.8%) | $59.81M(+22.9%) |
| Mar 2023 | - | $21.83M(+121.5%) | $48.65M(+38.3%) |
| Dec 2022 | $35.18M(+36.3%) | $9.85M(+11.2%) | $35.18M(+9.2%) |
| Sep 2022 | - | $8.86M(+9.3%) | $32.23M(+8.9%) |
| Jun 2022 | - | $8.11M(-3.0%) | $29.59M(+5.7%) |
| Mar 2022 | - | $8.36M(+21.1%) | $28.00M(+8.5%) |
| Dec 2021 | $25.80M(+94.5%) | $6.90M(+10.9%) | $25.80M(+5.6%) |
| Sep 2021 | - | $6.22M(-4.6%) | $24.44M(+19.1%) |
| Jun 2021 | - | $6.52M(+5.9%) | $20.52M(+22.9%) |
| Mar 2021 | - | $6.16M(+11.3%) | $16.70M(+25.9%) |
| Dec 2020 | $13.27M(+13.9%) | $5.54M(+140.8%) | $13.27M(+29.3%) |
| Sep 2020 | - | $2.30M(-15.0%) | $10.26M(-5.5%) |
| Jun 2020 | - | $2.71M(-0.6%) | $10.86M(-1.4%) |
| Mar 2020 | - | $2.72M(+7.5%) | $11.01M(-5.4%) |
| Dec 2019 | $11.65M | $2.53M(-12.6%) | $11.65M(-1.4%) |
| Sep 2019 | - | $2.90M(+1.4%) | $11.81M(+1.7%) |
| Jun 2019 | - | $2.86M(-14.9%) | $11.61M(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $3.36M(+24.6%) | $11.42M(+3.3%) |
| Dec 2018 | $11.05M(+1.3%) | $2.69M(-0.0%) | $11.05M(+1.3%) |
| Sep 2018 | - | $2.70M(+1.0%) | $10.90M(+1.8%) |
| Jun 2018 | - | $2.67M(-10.8%) | $10.71M(+0.8%) |
| Mar 2018 | - | $2.99M(+17.3%) | $10.62M(-2.7%) |
| Dec 2017 | $10.91M(+14.0%) | $2.55M(+1.8%) | $10.91M(+0.3%) |
| Sep 2017 | - | $2.50M(-3.1%) | $10.88M(+4.3%) |
| Jun 2017 | - | $2.58M(-21.3%) | $10.43M(+1.8%) |
| Mar 2017 | - | $3.28M(+30.4%) | $10.25M(+6.9%) |
| Dec 2016 | $9.57M(-6.6%) | $2.52M(+22.6%) | $9.58M(-1.9%) |
| Sep 2016 | - | $2.05M(-14.3%) | $9.77M(-7.1%) |
| Jun 2016 | - | $2.40M(-8.4%) | $10.52M(+0.4%) |
| Mar 2016 | - | $2.62M(-3.2%) | $10.47M(+2.1%) |
| Dec 2015 | $10.25M(+35.3%) | $2.70M(-3.4%) | $10.25M(+7.9%) |
| Sep 2015 | - | $2.80M(+19.0%) | $9.50M(+9.4%) |
| Jun 2015 | - | $2.35M(-1.9%) | $8.69M(-10.8%) |
| Mar 2015 | - | $2.40M(+22.6%) | $9.74M(+32.6%) |
| Dec 2014 | $7.57M(+330.3%) | $1.96M(-1.5%) | $7.34M(+27.5%) |
| Sep 2014 | - | $1.99M(-41.6%) | $5.76M(+34.5%) |
| Jun 2014 | - | $3.40M(+813.3%) | $4.28M(+385.4%) |
| Dec 2013 | $1.76M(-58.4%) | $372.30K(-27.0%) | $882.30K(-17.3%) |
| Sep 2013 | - | $510.00K(-8.4%) | $1.07M(-35.5%) |
| Dec 2012 | $4.23M | - | - |
| Dec 2012 | - | $556.90K(-49.2%) | $1.65M(+50.8%) |
| Sep 2012 | - | $1.10M | $1.10M |
FAQ
- What is Viridian Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual SG&A year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Viridian Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM SG&A year-on-year change?
What is Viridian Therapeutics, Inc. annual SG&A?
The current annual SG&A of VRDN is $61.08M
What is the all-time high annual SG&A for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual SG&A is $95.00M
What is Viridian Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, VRDN annual SG&A has changed by -$33.92M (-35.70%)
What is Viridian Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of VRDN is $0.00
What is the all-time high quarterly SG&A for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly SG&A is $32.99M
What is Viridian Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, VRDN quarterly SG&A has changed by -$16.07M (-100.00%)
What is Viridian Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of VRDN is -$4.18B
What is the all-time high TTM SG&A for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM SG&A is -$23.89M
What is Viridian Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, VRDN TTM SG&A has changed by -$4.26B (-5015.89%)